Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
1(7%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
7%
Ph phase_1
8
57%
Ph not_applicable
1
7%

Phase Distribution

8

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
8(80.0%)
Phase 3Large-scale testing
1(10.0%)
N/ANon-phased studies
1(10.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

1

trials recruiting

Total Trials

14

all time

Status Distribution
Active(3)
Completed(8)
Terminated(1)
Other(2)

Detailed Status

Completed8
unknown2
Not yet recruiting2
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 18 (80.0%)
Phase 31 (10.0%)
N/A1 (10.0%)

Trials by Status

unknown214%
recruiting17%
completed857%
withdrawn17%
not_yet_recruiting214%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials
NCT07156617

A Study on the Heterogeneity of Efficacy of Interventional Therapy Combined With Systemic Therapy for Liver Cancer Based on Multi-center Real-world Data

Not Yet Recruiting
NCT06927596

A Look Back at How Well Interventional Treatments Work for Bronchopleural Fistulas in Patients With Lung Metastases From Osteosarcoma

Not Yet Recruiting
NCT05912738

Muscle Elasticity Assessment of Postherpetic Neuralgia Using Elasticity Ultrasound

Unknown
NCT06449937Not Applicable

Local Liver Treatment for Multi-organ Colorectal Cancer Metastases

Recruiting
NCT02449135

Nano Drug Interventional Therapy Using Digital Subtraction Angiography(DSA) for Pancreatic Carcinoma

Unknown
NCT02449967Phase 1

HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA) for Pancreatic Cancer

Withdrawn
NCT02523404Phase 1

HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA)for Lung Cancer

Completed
NCT02523365Phase 1

HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA) for Cervical Carcinoma

Completed
NCT02523430Phase 1

HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA) for Nasopharyngeal Carcinoma

Completed
NCT02449122Phase 1

Nano Drug Interventional Therapy Using Digital Subtraction Angiography(DSA) for Lung Carcinoma

Completed
NCT02447263Phase 1

HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA) for Liver Cancer

Completed
NCT02523417Phase 1

HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA)for Breast Cancer

Completed
NCT02449109Phase 1

Nano Drug Interventional Therapy Using Digital Subtraction Angiography(DSA) for Liver Carcinoma

Completed
NCT00389181Phase 3

A Randomized Trial of Unruptured Brain AVMs

Completed

All 14 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
14